Back to results
US 11,529,319 B2Granted
Methods and compositions for treating neurological conditions
OwnerStuart A. Liptoninventor
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods for treating juvenile onset neurological conditions, such as autism (ASD), intellectual disability, or epilepsy, with an inhibitor of N-methyl-D-aspartate receptor (NMDAR). The inhibitor may be NitroSynapsin or a derivative thereof.
Claims15
A method of treating an Autism Spectrum Disorder (ASD) in a subject in need thereof with an inhibitor of N-methyl-D-aspartate type of glutamate receptor (NMDAR) wherein the inhibitor of NMDAR is NitroSynapsin:
- wherein each R1 is —CH2CH3 and R2 is —ONO2, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.